Giunchi F.; Franceschini T.; Gruppioni E.; Altimari A.; Capizzi E.; Massari F.; Schiavina R.; Brunelli M.; Martignoni G.; Fiorentino M., Similarities and differences between clear cell tubulo-papillary and conventional clear cell renal cell carcinoma: A comparative phenotypical and mutational analysis, «DIAGNOSTICS», 2020, 10, Article number: 123 , pp. 123 - 123 [Scientific article]Open Access
Di Nunno V.; Santoni M.; Mollica V.; Conti A.; Montironi R.; Battelli N.; Ardizzoni A.; Massari F., Systemic Treatment for Metastatic Hormone Sensitive Prostate Cancer: A Comprehensive Meta-Analysis Evaluating Efficacy and Safety in Specific Sub-Groups of Patients, «CLINICAL DRUG INVESTIGATION», 2020, 40, pp. 211 - 226 [Scientific article]
Mollica V.; Rizzo A.; Massari F., The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer, «FUTURE ONCOLOGY», 2020, 16, pp. 2029 - 2033 [Scientific article]
Cimadamore A.; Aurilio G.; Nole F.; Massari F.; Scarpelli M.; Santoni M.; Lopez-Beltran A.; Cheng L.; Montironi R., Update on circulating tumor cells in genitourinary tumors with focus on prostate cancer, «CELLS», 2020, 9, Article number: 1495 , pp. 1 - 18 [Scientific article]Open Access
Di Nunno V, Mollica V, Brunelli M, Gatto L, Schiavina R, Fiorentino M, Santoni M, Montironi R, Caliò A, Eccher A, Milella M, Martignoni G, Brunocilla E, Massari F, A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss., «MOLECULAR DIAGNOSIS & THERAPY», 2019, 23, pp. 569 - 577 [Scientific article]
Massari F.; Di Nunno V.; Mollica V.; Graham J.; Gatto L.; Heng D., Adjuvant Tyrosine Kinase Inhibitors in Treatment of Renal Cell Carcinoma: A Meta-Analysis of Available Clinical Trials, «CLINICAL GENITOURINARY CANCER», 2019, 17, pp. 339 - 344 [Scientific article]
Di Nunno, V.; Mollica, V.; Gatto, L.; Santoni, M.; Sorgentoni, G.; Battelli, N.; Massari, F., Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients?, «ANNALS OF TRANSLATIONAL MEDICINE», 2019, 7, pp. 38 - 42 [Scientific article]
Di Nunno, Vincenzo; Massari, Francesco; Mollica, Veronica; Cimadamore, Alessia; Santoni, Matteo; Cheng, Liang; Lopez-Beltran, Antonio; Scarpelli, Marina; Montironi, Rodolfo, Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma, «ANNALS OF TRANSLATIONAL MEDICINE», 2019, 7, Article number: S137 , pp. 1 - 6 [Scientific article]Open Access
Di Nunno V.; Frega G.; Santoni M.; Gatto L.; Fiorentino M.; Montironi R.; Battelli N.; Brandi G.; Massari F., BAP1 in solid tumors, «FUTURE ONCOLOGY», 2019, 15, pp. 2151 - 2162 [Scientific article]
Iacovelli, Roberto; Ciccarese, Chiara; Fornarini, Giuseppe; Massari, Francesco; Bimbatti, Davide; Mosillo, Claudia; Rebuzzi, Sara Elena; Di Nunno, Vincenzo; Grassi, Massimiliano; Fantinel, Emanuela; Ardizzoni, Andrea; Tortora, Giampaolo, Cabozantinib-related cardiotoxicity: a prospective analysis in a "real world" cohort of metastatic renal cell carcinoma patients, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2019, 85, pp. 1283 - 1289 [Scientific article]
Massari F.; Di Nunno V., CheckMate 214 patient-reported outcomes: listening to our patients, «THE LANCET ONCOLOGY», 2019, 20, pp. 179 - 180 [Scientific article]
Santoni M.; Cimadamore A.; Cheng L.; Lopez-Beltran A.; Battelli N.; Massari F.; Scarpelli M.; Galosi A.B.; Bracarda S.; Montironi R., Circulating tumor cells in renal cell carcinoma: Recent findings and future challenges, «FRONTIERS IN ONCOLOGY», 2019, 9, Article number: 228 , pp. 1 - 6 [Scientific article]Open Access
Gasparrini S.; Cimadamore A.; Scarpelli M.; Massari F.; Doria A.; Mazzucchelli R.; Cheng L.; Lopez-Beltran A.; Montironi R., Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians, «ASIAN JOURNAL OF ANDROLOGY», 2019, 21, pp. 19 - 23 [Scientific article]Open Access
Cimadamore A.; Gasparrini S.; Massari F.; Santoni M.; Cheng L.; Lopez-Beltran A.; Scarpelli M.; Montironi R., Emerging molecular technologies in renal cell carcinoma: Liquid biopsy, «CANCERS», 2019, 11, Article number: 196 , pp. 1 - 9 [Scientific article]Open Access
Prisciandaro M.; Ratta R.; Massari F., Erratum: Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program (American Journal of Clinical Oncology: Cancer Clinical Trials (2019) 42 (42-45) DOI: 10.1097/COC.0000000000000478), «AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS», 2019, 42, pp. 412 - 412 [Scientific article]
